CLINICAL_TRIALS
trial_result
· 2010-04-27
Clinical Trial Update: Study of the Bioequivalence of Two Tablet Forms of MK0431 (0431-027) [Phase 1]
Summary
This Phase 1 study evaluated the bioequivalence of two tablet formulations of MK0431 (0431-027) with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2010-04-27